Serum Institute of India (SII) is expanding its vaccine business in the United Kingdom with an investment of £240 million. The serum has already started phase one trials in the UK of a one-dose nasal vaccine for coronavirus, in partnership with Codagenix INC. This was a part of the £533 million of new Indian investment in the UK in growing sectors such as health and technology.
Buy Prime Test Series for all Banking, SSC, Insurance & other exams
Serum’s investment will support clinical trials, research & development and possibly manufacturing of vaccines. This will help the UK and the world to defeat the coronavirus pandemic and other deadly diseases.
Important takeaways for all competitive exams:
- The SII was founded by Cyrus Poonawalla (Adar Poonawalla’s father) in 1966.
- Adar Poonawalla joined the Serum Institute of India in 2001 and became the CEO of the company in 2011.
Billionaire Wealth Transfer Enters Histo...
Sunil Narine Makes T20 History With 600‑...
S-500 Missile System: Features, Range, S...
